Tip - Five Lessons From Niaspan's Disappointing Study

Comparative effectiveness research -- investigations that determine which treatments are best -- has attracted attention in the health care debate. Critics charge that these studies are designed to restrict choice. The Center for Medicine in the Public Interest released a report that suggested that they would stifle innovation. Often they [...]
Tags: Pharma and Health,Business,Pharma & Healthcare,Abbott Laboratories,Health,Heart disease,High-density lipoprotein,Low-density lipoprotein,National Institutes of Health,Niacin,Statin